Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Net Income
Net Income
EGP 344.21M
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2025 | 268.61M | -26.17% | 6.56% |
| 2024 | 363.84M | 62.79% | 13.14% |
| 2023 | 223.5M | -2.44% | 11.63% |
| 2022 | 229.08M | 37.68% | 15.44% |
| 2021 | 166.39M | 70.69% | 13.35% |
| 2020 | 97.48M | 18.31% | 10.15% |
| 2019 | 82.39M | -36.14% | 9.22% |
| 2018 | 129.02M | 44.24% | 16.02% |
| 2017 | 89.45M | — | 14.23% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.